Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC4XD.L Regulatory News (C4XD)

  • There is currently no data for C4XD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

20 Sep 2017 10:04

RNS Number : 2745R
C4X Discovery Holdings PLC
20 September 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

C4X DISCOVERY HOLDINGS PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

CANACCORD GENUITY GROUP INC

City and country of registered office (if applicable)

VANCOUVER, CANADA

4. Full name of shareholder(s) (if different from 3.)v

Name

DISCRETIONARY CLIENTS

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

18 SEPTEMBER 2017

6. Date on which issuer notified (DD/MM/YYYY):

19 SEPTEMBER 2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

5.4581%

0.00

5.4581%

46,555,087

Position of previous notification (if

applicable)

N/A

N/A

N/A

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BQQ2RV18

N/A

2,541,000

N/A

5.4581%

SUBTOTAL 8. A

2,541,000

5.4581%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Canaccord Genuity Group Inc.[1]

5.4581%

5.4581%

Canaccord Genuity Wealth Group Holdings Limited

5.4581%

5.4581%

Canaccord Genuity Wealth Group Holdings (Jersey) Limited

5.4581%

5.4581%

Hargreave Hale Limited

5.4581%

5.4581%

[1] Each company set out in this table is ultimately owned by Canaccord Genuity Group Inc.

 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

This disclosable event is as a result of the acquisition of Hargreave Hale Limited by Canaccord Genuity Group Inc., through its wholly-owned subsidiary Canaccord Genuity Wealth Group Holdings (Jersey) Limited.

 

 

 

Place of completion

London

Date of completion

19/09/17

 


 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLIFIAAIIIFID
Date   Source Headline
25th Jun 20197:00 amRNSC4X Discovery collaboration with PhoreMost
30th Apr 20197:00 amRNSInterim results
18th Mar 20197:00 amRNSNotice of Results
6th Mar 201911:19 amRNSPDMR Shareholdings
15th Jan 201910:28 amRNSResult of AGM
17th Dec 20187:00 amRNSC4X Discovery partnership with Horizon Discovery
11th Dec 201811:48 amRNS2018 Annual Report
6th Dec 20187:00 amRNSC4X Discovery collaboration with E-Therapeutics
29th Nov 20187:00 amRNSDiscovery partnership with GTN Ltd.
27th Nov 20187:00 amRNSDiscovery partnership with LifeArc
21st Nov 20187:00 amRNSFull year results for the year ended 31 July 2018
9th Nov 20187:00 amRNSNotice of Results
22nd Oct 20187:00 amRNSPDMR Shareholding
19th Oct 20184:33 pmRNSExercise of Options and Issue of Equity
16th Oct 20189:45 amRNSGrant of Options and Director Dealing
10th Oct 20183:26 pmRNSNotification of major holdings
10th Oct 20183:22 pmRNSNotification of major holdings
10th Oct 20181:04 pmRNSHoldings in Company
10th Oct 20187:00 amRNSHoldings in Company
5th Oct 201811:11 amRNSResult of General Meeting
5th Oct 201810:29 amRNSProposed Placing, Open Offer and Notice of GM
18th Sep 20184:53 pmRNSResults of Placing
18th Sep 20181:53 pmRNSProposed Placing, Open Offer and Notice of GM
24th Jul 20187:00 amRNSC4X3256 programme awarded $480k NIDA grant
4th Jul 20187:00 amRNSBoard Changes
1st May 20187:00 amRNSCollaboration with e-Therapeutics
17th Apr 201812:50 pmRNSDirector/PDMR Shareholding
17th Apr 20187:00 amRNSDirector/PDMR Shareholding
12th Apr 20187:00 amRNSInterim results
10th Apr 20187:00 amRNSNotice of Results
29th Mar 20187:00 amRNSIndivior deal worth up to $294 Million
18th Jan 20182:36 pmRNS2017 Annual Report
16th Jan 201810:46 amRNSResult of AGM
14th Dec 20177:00 amRNSFull year results for the year ended 31 July 2017
12th Dec 20177:00 amRNSNotice of Results
13th Nov 20177:00 amRNSC4XD presents data on Orexin-1 antagonist
20th Sep 201710:04 amRNSHolding(s) in Company
6th Sep 201711:51 amRNSPDMR Shareholdings
5th Sep 20177:00 amRNSBusiness Update
8th Jun 20171:04 pmRNSIssue of Equity
5th Jun 201710:21 amRNSHolding(s) in Company
27th Apr 20177:00 amRNSInterim results for six months ended 31 Jan 2017
18th Apr 20177:00 amRNSNotice of Results
6th Apr 20178:03 amRNSHolding(s) in Company
5th Apr 20175:49 pmRNSHolding(s) in Company
5th Apr 201712:24 pmRNSHoldings in Company
3rd Apr 20175:22 pmRNSHolding(s) in Company
3rd Apr 20175:21 pmRNSHolding(s) in Company
31st Mar 201710:42 amRNSResult of General Meeting and Issue of Equity
14th Mar 20171:30 pmRNSResults of Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.